Birgitta Henriques Normark

Title: Birgitta Henriques Normark: Innovator in Vaccine Development

Introduction

Birgitta Henriques Normark is a prominent inventor based in Stockholm, Sweden. She has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 2 patents, her work focuses on innovative solutions to combat bacterial infections.

Latest Patents

Birgitta's latest patents include groundbreaking research on streptococcal vaccines. One patent describes an immunogenic composition that comprises bacterial membrane vesicles (MVs) containing a streptococcal MalX antigen and/or a streptococcal PrsA antigen. This composition is characterized by the absence of an immunogenic amount of a streptococcal PspA antigen. The membrane vesicles may also be artificial membrane particles, with medical applications particularly aimed at immunization against pneumococcal disease. Another patent involves isolated membrane vesicle microparticles (MPs) that include specific proteins at defined levels, which are crucial for immunization. These compositions and their manufacturing methods represent significant advancements in vaccine technology.

Career Highlights

Birgitta is currently associated with Zalvac AB, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of vaccine formulations and their applications in public health.

Collaborations

Throughout her career, Birgitta has collaborated with notable colleagues, including Staffan Normark and Federico Iovino. These partnerships have fostered innovation and contributed to the success of her research initiatives.

Conclusion

Birgitta Henriques Normark stands out as a key figure in the field of vaccine development. Her innovative patents and ongoing research efforts continue to pave the way for advancements in immunization strategies.